Enovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Enovis (NYSE: ENOV) announced management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 11, 2026 in Snowbird, UT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Enovis (NYSE: ENOV) announced management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 11, 2026 in Snowbird, UT. The notice confirms a company presentation but contains no financial data or guidance.
Details
News Market Reaction – ENOV
On Feb 3, the day this news came out, ENOV closed 1.71% below the previous close.
Data tracked by StockTitan Argus for the Feb 3 session.
Key Figures
- Conference date
- February 11, 2026
- BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Historical Context
-
Announcement of upcoming Q4 and full-year 2025 earnings call and webcast.
-
Management participation in the 44th Annual J.P. Morgan Healthcare Conference.
-
Appointment of a new Chief Administrative Officer to drive growth and efficiency.
-
Q3 2025 results with sales growth but large goodwill impairment and net loss.
-
Scheduling Q3 2025 earnings call and participation in upcoming investor conferences.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
medtech technical
digital health technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Dallas TX, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 11, 2026 in Snowbird, UT.
About Enovis
Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. Enovis solutions impact the well-being of millions of patients wherever they are on their pathway to health. Discover more about Enovis at www.enovis.com
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.